|
|
|
|
|
|
|
|
类别 |
产品号 |
产品名称 |
英文名称 |
CAS# |
溶剂 |
浓度 |
包装 |
兽药混标
Veterinary Mix Solution |
1STG47033-100M |
23种磺胺混标(GB/T21316-2007) |
23 Sulfonamides Mix
Solution, 100ppm |
/ |
甲醇 |
100ppm |
1ml |
组份: |
|
|
|
|
|
|
|
|
1ST4043 |
磺胺脒 (SGN); 磺胺胍 |
Sulfaguanidine |
57-67-0 |
|
|
|
|
1ST4009 |
甲氧苄氨嘧啶; 甲氧苄啶 (TMP) |
Trimethoprim |
738-70-5 |
|
|
|
|
1ST4039 |
磺胺二甲异嘧啶; 磺胺索嘧啶 (SIM) |
Sulfisomidine;
Sulfaisodimidine |
515-64-0 |
|
|
|
|
1ST4001 |
磺胺醋酰 (SAA) |
Sulfacetamide |
144-80-9 |
|
|
|
|
1ST4017 |
磺胺嘧啶 (SDZ) |
Sulfadiazine |
68-35-9 |
|
|
|
|
1ST4003 |
磺胺吡啶 (SPD) |
Sulfapyridine |
144-83-2 |
|
|
|
|
1ST4007 |
磺胺噻唑 (STZ) |
Sulfathiazole |
72-14-0 |
|
|
|
|
1ST4002 |
磺胺甲基嘧啶 (SMR) |
Sulfamerazine |
127-79-7 |
|
|
|
|
1ST4011 |
磺胺恶唑 (SMO) |
Sulfamoxole |
729-99-7 |
|
|
|
|
1ST4014 |
磺胺二甲基嘧啶 (SDM) |
Sulfamethazine;
Sulfadimidine |
57-68-1 |
|
|
|
|
1ST4004 |
磺胺甲氧哒嗪 (SMP) |
Sulfamethoxypyridazine |
80-35-3 |
|
|
|
|
1ST4008 |
磺胺甲噻二唑 (SMT) |
Sulfamethizole |
144-82-1 |
|
|
|
|
1ST4036 |
磺胺对甲氧嘧啶 (SMD) |
Sulfameter;
Sulfamethoxydiazine |
651-06-9 |
|
|
|
|
1ST4040 |
磺胺间甲氧嘧啶 (SMM) |
Sulfamonomethoxine |
1220-83-3 |
|
|
|
|
1ST4034 |
磺胺氯哒嗪 (SCP) |
Sulfachloropyridazine |
80-32-0 |
|
|
|
|
1ST4006 |
磺胺多辛; 磺胺邻二甲氧嘧啶 (SDX) |
Sulfadoxine |
2447-57-6 |
|
|
|
|
1ST4005 |
磺胺甲恶唑; 磺胺甲基异噁唑 (SMZ) |
Sulfamethoxazole |
723-46-6 |
|
|
|
|
1ST4010 |
磺胺二甲异噁唑; 磺胺异恶唑 (SFZ) |
Sulfisoxazole;
Sulfafurazole |
127-69-5 |
|
|
|
|
1ST4012 |
苯甲酰磺胺; 磺胺苯酰(SBA) |
Sulfabenzamide |
127-71-9 |
|
|
|
|
1ST4042 |
磺胺间二甲氧嘧啶; 磺胺二甲氧嘧啶;
磺胺二甲氧哒嗪; 磺胺地索辛 (SDT) |
Sulfadimethoxine |
122-11-2 |
|
|
|
|
1ST4028 |
磺胺喹恶啉; 磺胺喹沙啉 (SQX) |
Sulfaquinoxaline |
59-40-5 |
|
|
|
|
1ST4013 |
磺胺苯吡唑 (SPA) |
Sulfaphenazole |
526-08-9 |
|
|
|
|
1ST4044 |
磺胺硝苯 (SAN) |
Sulfanitran |
122-16-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|